Elutia Inc. (ELUT:NASDAQ) closed at $0.838 on October 23, 2026, down 2.61% on the day. The stock trades 39.5% below its 52-week high of $1.39 and 67.5% above its 52-week low of $0.500. Over the past year, it lost 6.9%. Elutia Inc. is part of the Health Care sector.
In 252 trading sessions since October 23, 2025, ELUT closed higher on 106 days (42%). Its best day was January 13, 2026 (+27.14%) and its worst was December 16, 2025 (-18.66%). The stock moved 10% or more in a single session 6 times.
Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.
Find more stocks like ELUT with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.